Effect of silver nanoparticle geometry on methicillin susceptible and resistant Staphylococcus aureus, and osteoblast viability

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 7, 2015, Pages

  Actis, Lisa ^a   Srinivasan, Anand ^a   Lopez Ribot, Jose L ^b   Ramasubramanian, Anand K ^a   Ong, Joo L ^a  

^a The University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOMATERIALS; GEOMETRY; METAL NANOPARTICLES; SYNTHESIS (CHEMICAL);

ANTI-BACTERIAL ACTIVITY; ANTIBIOTIC-RESISTANT BACTERIA; BACTERIAL INFECTIONS; CHEMICAL REDUCTION METHODS; NANOPARTICLE CONCENTRATIONS; NANOPARTICLE GEOMETRIES; RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

SILVER NANOPARTICLES;

CUBE SHAPED SILVER NANOPARTICLE; SILVER NANOPARTICLE; SPHERE SHAPED SILVER NANOPARTICLE; TRIANGLE SHAPED SILVER NANOPARTICLE; UNCLASSIFIED DRUG; METAL NANOPARTICLE; SILVER;

ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOFILM; CELL ADHESION; CELL STRUCTURE; CELL VIABILITY; COLORIMETRY; FETUS; FLUORESCENCE ANALYSIS; GEOMETRY; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROSCOPY; NANOFABRICATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; BACTERIUM ADHERENCE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

BACTERIAL ADHESION; BIOFILMS; CELL LINE; HUMANS; METAL NANOPARTICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OSTEOBLASTS; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84938882132     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5538-8     Document Type: Article

References (26)

1. Campoccia D, Montanaro L, Arciola CR. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces. Biomaterials. 2013;34:8018–29.
2. Evan M, Hetrick MHS. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35:780–9.
3. Romeo T, editor. Bacterial biofilms. Current topics in microbiology and immunology, vol. 322. Berlin: Springer; 2008.
4. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006;19:349–56.
5. Flemming H-C. Biofilm highlights. Springer Series on Biofilms. New York: Springer; 2011.
6. Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43(15):6046–51.
7. Zimmerli W. Prosthetic-join-associated infections. Best Pract Res Clin Rheumatol. 2006;20(6):1045–63.
8. Ribeiro M, Monteiro FJ, Ferraz MP. Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter. 2012;2(4):176–94.
9. Leid JG, Leid J, Shirtliff M, editors. The role of biofilm in device-related infections. Springer Series on Biofilms. Los Angeles: Springer; 2009.
10. Vasilev K, Cook J, Griesser HJ. Antibacterial surfaces for biomedical devices. Exp Rev Med Devices. 2009;6(5):553–67.
11. Lara HH, Garza-Treviño EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnol. 2011;9(1):30.
12. Tran QH, Le AT. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol. 2013;4:033001.
13. Dal Lago V, de Oliveira LF, de Almeida Gonçalves K, Kobarg J, Cardoso MB. Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties. J Mater Chem. 2011;21(33):12267–73.
14. Marambio-Jones C, Hoek EM. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010;12:1531–51.
15. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73(6):1712–20.
16. Metraux GS, Mirkin CA. Rapid thermal synthesis of silver nanoprisms with chemically tailorable thickness. Adv Mater. 2005;17(4):412–5.
17. Sun Y, Xia Y. Shape-controlled synthesis of gold and silver nanoparticles. Science. 2002;298:2176–9.
18. Yguerabide J, Yguerabide EE. Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. Anal Biochem. 1998;262:137–56.
19. Chen Z, Gao L. A facile and novel way for the synthesis of nearly monodisperse silver nanoparticles. Mater Res Bull. 2007;42:1657–61.
20. Mansouri SS, Ghader S. Experimental study of effect of different parameters on size and shape of triangular silver nanoparticles prepared by a simple and rapid method in aqueous solution. Arab J Chem. 2009;2:47–53.
21. Chen S, Carroll DL. Silver nanoplates: size control in two dimensions and formulation mechanism. J Phys Chem B. 2004;108:5500–6.
22. Skrabalak SE, Au L, Li X, Xia Y. Facile synthesis of Ag nanocubes and Au nanocages. Nat Protoc. 2007;2(9):2182–90.
23. Mdluli PS, Sosibo NM, Mashazi PN, Nyokong T, Tshikhudo RT, Skepu A, Van Der Lingen E. Selective adsorption of PVP on the surface of silver nanoparticles: a molecular dynamics study. J Mol Struct. 2011;1004:131–7.
24. Kvitek L, Panáček A, Soukupova J, Kolar M, Vecerova R, Prucek R, et al. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C. 2008;112:5825–34.
25. Pauksch L, Hartmann S, Rohnke M, Szalay G, Alt V, Schnettler R, Lips KS. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater. 2014;10:439–49.
26. Tautzenberger A, Kovtun A, Ignatius A. Nanoparticles and their potential application in bone. Int J Nanomed. 2012;7:4545–57.